Questions? 10 seconds to sign up
Join the platform
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
March 5, 2026
Approximately 5 minutes
Obtaining Scientific Advice from MHRA for Medicines Development
Obtaining Scientific Advice from MHRA for Medicines Development
1. Overview
You can request scientific advice from the MHRA at any stage of your medicine’s development or regulation. This includes written advice only or meetings, with written summaries provided after some meetings. Advice can be specific to a single development programme or broader. Joint meetings with the MHRA and NICE are available. The advice is based on provided questions and documents, not accounting for future changes, and is not legally binding. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
2. Process and Timelines
The timeline varies by subject and expertise. Early planning is encouraged. For meetings, final questions and briefing documents must be sent 15 working days in advance, or the meeting will be delayed. Written summaries, if provided, are sent within 30 working days post-meeting. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
3. MHRA Expertise
MHRA offers expertise across the medicine lifecycle. Clear, specific questions ensure access to relevant experts. Guidance on formulating questions is in the supporting documents section. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
4. Types of Meetings
4.1 Scientific Advice Meeting
Targeted for individual products, encouraged at key stages like first-in-human studies, pivotal trials, CMC requirements, bioequivalence studies, and reclassification. Meetings last up to 90 minutes, with written advice provided afterward. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
4.2 Broader Scope Advice Meeting
For general approaches, complex plans, endpoints, etc., not product-specific. Meetings up to 90 minutes, no written advice provided. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
5. Joint Scientific Advice with MHRA and NICE
Detailed guidance on integrated service available. Access via specific portal. Collaboration aims for aligned decisions and faster patient access. Webinar link provided. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
6. Requesting Scientific Advice
Use the online form for requests. Prepare necessary documents beforehand. MHRA processes upon receiving complete questions list. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
7. Supporting Documents
Upload briefing documents and questions. Documents due 15 working days before meetings. Briefing includes presentations, labelling examples; appendices for background. Questions focus on specific issues like quality, non-clinical, clinical aspects. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
8. Before the Meeting
Send briefing documents 15 working days prior. MHRA may provide provisional advice or questions. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
9. At the Meeting
Start with short presentation. Meetings may be recorded for internal use. Provide notes within 15 working days post-meeting. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
10. After the Meeting
Send notes within 15 days. MHRA sends advice letter within 6 weeks for applicable meetings. Clarifications via email or meeting, but no scope expansion without additional fees. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
11. Limitations of Advice
Advice is without prejudice, does not override laws or affect third-party IP rights. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
12. Fees
Fees detailed in linked publication. Pay via link, 15 days before meeting. UK SMEs with status exempt. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
13. Contact
Email: scientific_advice@mhra.gov.uk https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
14. Publication and Updates
Published 29 December 2014, last updated 4 March 2026. Multiple updates listed. https://www.gov.uk/guidance/medicines-get-scientific-advice-from-mhra
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Guide to Manufacturer and Wholesaler Licences for Medicines in the UK
This guide explains how to apply for, update, and cancel licences for manufacturing, importing, and wholesaling human and veterinary medicines in the UK, including compliance with GMP and GDP, application processes, fees, and inspections.
Approximately 5 minutes
Reclassifying Medicines in the UK: From Prescription to Over-the-Counter
This guide details the process for reclassifying medicines in the UK from prescription-only (POM) to pharmacy (P) or general sale list (GSL) status, including requirements, evidence, procedures, and public consultations to ensure safe public access.
Approximately 5 minutes
Obtaining Scientific Advice from MHRA for Medicines Development
The MHRA provides scientific advice on medicines at any development stage, offering written advice or meetings, including joint sessions with NICE, to guide regulatory and development strategies.
Approximately 5 minutes
Supplying Authorised Medicines to Northern Ireland Under the Windsor Framework
This guidance details the regulations for supplying authorised medicines to Northern Ireland from 1 January 2025, including UK-wide marketing authorisations, supply from Great Britain, and identification of compliant medicines under the Windsor Framework.